1. Advances in the development of therapeutic nucleic acids against cervical cancer
   Joseph A DiPaolo et al, 2004, Expert Opinion on Biological Therapy CrossRef
2. Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation
   Thomas Hiller et al, 2008, Journal of Medical Virology CrossRef
3. Effect of Combined Antisense Oligodeoxynucleotides Directed against the Human Papillomavirus Type 16 on Cervical Carcinoma Cells
   Miguel A. Márquez-Gutiérrez et al, 2007, Archives of Medical Research CrossRef
4. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes
   Luis M. Alvarez-Salas et al, 1998, Proceedings of the National Academy of Sciences CrossRef
5. Comparison of Variant-Specific Hybridization and Single-Strand Conformational Polymorphism Methods for Detection of Mixed Human Papillomavirus Type 16 Variant Infections
   Rebecca T. Emeny et al, 1999, Journal of Clinical Microbiology CrossRef
6. Growth Inhibition of Cervical Tumor Cells by Antisense Oligodeoxynucleotides Directed to the Human Papillomavirus Type 16 E6 Gene
   LUIS M. ALVAREZ-SALAS et al, 1999, Antisense and Nucleic Acid Drug Development CrossRef
7. Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology
   Ingeborg Zehbe et al, 1997, The Journal of Pathology CrossRef
8. Advances in the Development of Ribozymes and Antisense Oligodeoxynucleotides as Antiviral Agents for Human Papillomaviruses
   Luis Maret Alvarez-Salas et al, 2003, Antiviral Therapy CrossRef